Calithera market cap
WebMar 29, 2024 · Calithera Biosciences ( NASDAQ: CALA) has slipped 21.38% after-hours on announcing an underwritten public offering of common stock and warrants to purchase common stock. The biopharmaceutical... WebStock Price Forecast. The 1 analysts offering 12-month price forecasts for Calithera Biosciences Inc have a median target of 8.00, with a high estimate of 8.00 and a low …
Calithera market cap
Did you know?
WebMar 31, 2024 · Calithera Biosciences, Inc. filed its 10-K on Mar 31, 2024 for the period ending Dec 31, 2024. ... Top Capitalization. United States. North America. Europe. Asia. Middle East. Sector Research. Financial Calendar. ... SVB Securities Downgrades Calithera Biosciences to Market Perform From Outperform, Adju.. MT. WebApr 11, 2024 · Calithera Biosciences (NASDAQ:CALA) has a market capitalization of $243,500.00 and generates $9.75 million in revenue each year. The biotechnology …
WebMarket Cap (Capitalization) is a measure of the estimated value of the common equity securities of the company or their equivalent. It does not include securities convertible … WebSep 8, 2024 · Market Cap: $187.13B Total Employees: ~83,100 Headquarters: Cambridge, United Kingdom Stock Exchange: LON AstraZeneca is a multinational pharma and biotech company that delivers products in therapeutic areas including Oncology, Cardiology, Gastrointestinal infections, and Inflammation.
WebCalithera is a clinical-stage biopharmaceutical company pioneering the discovery and development of targeted, small molecule therapies that disrupt cellular metabolic … WebThe profitability module also shows relationships between Calithera Biosci's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Calithera Biosci Com over time as well as its relative position and ranking within its peers.
WebFeb 1, 2024 · A high-level overview of Calithera Biosciences, Inc. (CALA) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and …
WebJan 4, 2024 · Calithera Biosciences ( CALA 1.92%), a clinical-stage biotech company, reported on Monday morning that telaglenastat, one of its leading pipeline candidates, … the gambler series castWeb26 rows · Mar 22, 2024 · Market Capitalization Definition Market Capitalization measures the total value of a company based on their stock price multiplied by the shares … the gamblers bookstore las vegasWebCalithera Biosciences Inc (NASDAQ: CALA) announced that its Board of Directors has determined that it is in the best interests of its shareholders to dissolve the company and liquidate its assets. Find the latest Calithera Biosciences, Inc. (CALA) stock discussion in Yahoo … Discover historical prices for CALA stock on Yahoo Finance. View daily, weekly or … Calithera Biosciences Reports Third Quarter 2024 Financial Results and … Find out all the key statistics for Calithera Biosciences, Inc. (CALA), including … Holder Shares Date Reported % Out Value; Primecap Odyssey Aggressive Growth … Get the detailed quarterly/annual income statement for Calithera Biosciences, Inc. … See the company profile for Calithera Biosciences, Inc. (CALA) including … Find the latest Calithera Biosciences, Inc. (CALA) stock quote, history, news and … View the basic CALA option chain and compare options of Calithera … At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio … the gamblers game ritual